Biostar Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '17 Sep 30, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Net Income	0.93	-5.7	-25.11	4.85	0.81	-20
Depreciation & Amortization	1.11	1.14	2.32	3.09	2.79	1.83
Other Amortization	-	-	1.07	-	-	-
Loss (Gain) From Sale of Assets	-	-	0.74	-1.09	-1.17	-
Asset Writedown & Restructuring Costs	-	-	6.99	5.38	3.47	4.48
Stock-Based Compensation	-	-	-	2.02	0.76	0.82
Provision & Write-off of Bad Debts	-8.09	-0.27	4.67	-	-1.29	3.67
Other Operating Activities	2.18	2.43	1.01	-4.86	1.31	-0.69
Change in Accounts Receivable	13.94	8.67	5.45	-7.44	4.2	6.63
Change in Inventory	0.27	0.06	0.42	0.15	0.04	0.54
Change in Accounts Payable	-1.41	-1.09	-0.6	0.57	-1.45	3.2
Change in Income Taxes	-	-	-	0.31	-0.1	-1.92
Change in Other Net Operating Assets	-0.36	-0.33	0.08	0.33	-0.46	-2.14
Operating Cash Flow	8.59	4.91	5.88	3.31	8.91	-3.58
Operating Cash Flow Growth	22.76%	-16.41%	77.53%	-62.84%	-	-
Capital Expenditures	-	-	-0.06	-2.87	-0.98	-0.03
Sale of Property, Plant & Equipment	-	-	-	0	-	0.02
Cash Acquisitions	-10.79	-6.38	-8.12	-4.88	-3.87	-0.82
Sale (Purchase) of Intangibles	-	-	-	-1.13	0.65	-6.95
Other Investing Activities	-	-	-	-	-	-9.51
Investing Cash Flow	-10.79	-6.38	-7.38	-8.88	-4.21	-17.29
Short-Term Debt Issued	-	-	-	3.25	-	6.34
Total Debt Issued	-	-	-	3.25	-	6.34
Short-Term Debt Repaid	-	-0.28	-0.16	-0.16	-6.46	-0.79
Total Debt Repaid	0	-0.28	-0.16	-0.16	-6.46	-0.79
Net Debt Issued (Repaid)	0	-0.28	-0.16	3.09	-6.46	5.55
Issuance of Common Stock	1.07	1.07	-	2.9	-	-
Other Financing Activities	0.62	0.62	-	0.96	-	-
Financing Cash Flow	1.69	1.41	-0.16	6.95	-6.46	5.55
Foreign Exchange Rate Adjustments	0.21	0.19	0.01	0.22	0.08	0.11
Net Cash Flow	-0.29	0.13	-1.65	1.61	-1.68	-15.21
Free Cash Flow	8.59	4.91	5.82	0.44	7.93	-3.62
Free Cash Flow Growth	23.27%	-15.56%	1217.98%	-94.43%	-	-
Free Cash Flow Margin	2702.11%	206.03%	21.44%	0.72%	15.03%	-7.33%
Free Cash Flow Per Share	3.28	2.14	2.63	0.21	4.82	-2.65
Cash Interest Paid	-	0.04	0.13	0.15	0.36	0.06
Cash Income Tax Paid	-	-	-	0.67	0.97	2.39
Levered Free Cash Flow	7.47	6.69	20.68	-3.19	6.18	-8.16
Unlevered Free Cash Flow	7.59	6.82	20.86	-3.09	6.41	-8.11
Change in Working Capital	12.45	7.31	5.35	-6.08	2.24	6.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.